NR3C1 and metabolic disease: Taking account that the deregulation of GC homeostasis is associated with the development of obesity and the alteration of glucose and lipid metabolism, our results suggest that hepatic GR sensitivity may play an important role in development or treatment in the metabolic disorders associated with obesity.